Skip to main content

New insights into cellular mechanisms during sepsis

Immunologic Research volume 34, pages 133–141 (2006)Cite this article

Abstract

Despite intensive ongoing research efforts, the mortality of patients with sepsis remains unacceptably high. Clinical trials emerging from promising results in animal models have mostly failed to deliver sufficient treatment strategies so far. Many studies investigating the underlying mechanisms of sepsis have focused on deterioration of the humoral and cellular components of the immune system. However, in addition to septic shock, the main cause of death in septic patients is multiorgan failure. So far, not much is known about the effects of a dysregulated immune system as seen in sepsis on parenchymal cells of end organs. Studies on the interaction of the complement system and kidney as well as liver cells resulted in interesting yet still inconclusive data. In this review, we provide new insights into mechanisms during sepsis based on recent findings.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348 (16): 1546–1554.

    PubMed  Article  Google Scholar 

  2. Muckart DJ, Bhagwanjee A: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. Crit Care Med 1997; 25 (1): 1789–1795.

    PubMed  Article  CAS  Google Scholar 

  3. Bone RC: Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996; 24 (7): 1125–1128.

    PubMed  Article  CAS  Google Scholar 

  4. Riedemann NC, Guo RF, Bernacki KD, et al: Regulation by C5a of neutrophil activation during sepsis. Immunity 2003; 19 (2): 193–202.

    PubMed  Article  CAS  Google Scholar 

  5. Hebert PC, Drummond AJ, Singer J, Bernard GR, Russell JA: A simple multiple system organ failure scoring system predicts mortality of patients who have sepsis syndrome. Chest 1993; 104 (1): 230–235.

    PubMed  Article  CAS  Google Scholar 

  6. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ: Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995; 23 (10): 1638–1652.

    PubMed  Article  CAS  Google Scholar 

  7. Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL: Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001; 286 (14): 1754–1758.

    PubMed  Article  CAS  Google Scholar 

  8. Goya T, Morisaki T, Torisu M: Immunologic assessment of host defense impairment in patients with septic multiple organ failure: relationship between complement activation and changes in neutrophil function. Surgery 1994; 115 (2): 145–155.

    PubMed  CAS  Google Scholar 

  9. Welbourn CR, Goldman G, Paterson IS, Valeri CR. Shepro D, Hechtman HB: Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil. Br J Surg 1991; 78 (6): 651–655.

    PubMed  Article  CAS  Google Scholar 

  10. Windsor AC, Mullen PG, Fowler AA, Sugerman HJ: Role of the neutrophil in adult respiratory distress syndrome. Br J Surg 1993; 80 (1): 10–17.

    PubMed  Article  CAS  Google Scholar 

  11. Huber-Lang M, Sarma VJ, Lu KT, et al: Role of C5a in multiorgan failure during sepsis. J Immunol 2001; 166 (2): 1193–1199.

    PubMed  CAS  Google Scholar 

  12. Czermak BJ, Sarma V, Pierson CL, et al: Protective effects of C5a blockade in sepsis. Nat Med 1999; 5 (7): 788–792.

    PubMed  Article  CAS  Google Scholar 

  13. Huber-Lang MS, Younkin EM, Sarma JV, et al: Complement-induced impairment of innate immunity during sepsis. J Immunol 2002; 169 (6): 3223–3231.

    PubMed  CAS  Google Scholar 

  14. Cain SA, Monk PN: The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74). J Biol Chem 2002; 277 (9): 7165–7169.

    PubMed  Article  CAS  Google Scholar 

  15. Verdrengh M, Tarkowski A: Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus. Infect Immun 1997; 65 (7): 2517–2521.

    PubMed  CAS  Google Scholar 

  16. Czuprynski CJ, Theisen C, Brown JF: Treatment with the antigranulocte monoclonal antibody RB6-8C5 impairs resistance of mice to gastrointestinal infection with Listeria monocytogenes. Infect Immun 1996; 64 (9): 3946–3949.

    PubMed  CAS  Google Scholar 

  17. Han Y, Cutler JE: Assessment of a mouse model of neutropenia and the effect of an anti-candidiasis monoclonal antibody in these animals. J Infect Dis 1997; 175 (5): 1169–1175.

    PubMed  CAS  Article  Google Scholar 

  18. Sisley AC, Desai T, Harig JM, Gewertz BL: Neutrophil depletion attenuates human intestinal reperfusion injury. J Surg Res 1994; 57 (1): 192–196.

    PubMed  Article  CAS  Google Scholar 

  19. Dovi JV, He LK, DiPietro LA: Accelerated wound closure in neutrophil-depleted mice. J Leukoc Biol 2003; 73 (4): 448–455.

    PubMed  Article  CAS  Google Scholar 

  20. Hewett JA, Schultze AE, VanCise S, Roth RA: Neutrophil depletion protects against liver injury from bacterial endotoxin. Lab Invest 1992; 66 (3): 347–361.

    PubMed  CAS  Google Scholar 

  21. Molnar RG, Wang P, Ayala A, Ganey PE, Roth RA, Chaudry IH: The role of neutrophils in producing hepatocellular dysfunction during the hyperdynamic stage of sepsis in rats. J Surg Res 1997; 73 (2): 117–122.

    PubMed  Article  CAS  Google Scholar 

  22. Sato T, Shinzawa H, Abe Y, Takahashi T, Arai S, Sendo F: Inhibition of Corynebacterium parvum-primed and lipopolysaccharide-induced hepatic necrosis in rats by selective depletion of neutrophils using a monoclonal antibody. J Leukoc Biol 1993; 53 (2): 144–150.

    PubMed  CAS  Google Scholar 

  23. Heinzelmann M, Mercer-Jones MA, Passmore JC: Neutrophils and renal failure. Am J Kidney Dis 1999; 34 (2): 384–399.

    PubMed  CAS  Google Scholar 

  24. Hoesel LM, Neff TA, Neff SB, et al: Harmful and protective roles of neutrophils in sepsis. Shock 2005: 24 (1): 40–47.

    PubMed  Article  CAS  Google Scholar 

  25. Haslett C: Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin Sci (Lond) 1992; 83 (6): 639–648.

    CAS  Google Scholar 

  26. Jimenez MF, Watson RW, Parodo J, et al: Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome. Arch Surg 1997; 132 (12): 1263–1269; discussion 1269–1270.

    PubMed  CAS  Google Scholar 

  27. Gerard NP, Hodges MK, Drazen JM, Weller PF, Gerard C: Characterization of a receptor for C5a anaphylatoxin on human eosinophils. J Biol Chem 1989; 264 (3): 1760–1766.

    PubMed  CAS  Google Scholar 

  28. Gerard NP, Gerard C: The chemotactic receptor for human C5a anaphylatoxin. Nature 1991; 349 (6310): 614–617.

    PubMed  Article  CAS  Google Scholar 

  29. Chenoweth DE, Hugli TE: Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. Proc Natl Acad Sci USA 1978; 75 (8): 3943–3947.

    PubMed  Article  CAS  Google Scholar 

  30. Kurimoto Y, de Weck AL, Dahinden CA: Interleukin 3-dependent mediator release in basophils triggered by C5a. J Exp Med 1989; 170 (2): 467–479.

    PubMed  Article  CAS  Google Scholar 

  31. Werfel T, Oppermann M, Schulze M, Krieger G, Weber M, Gotze O: Binding of fluorescein-labeled anaphylatoxin C5a to human peripheral blood, spleen, and bone marrow leukocytes. Blood 1992; 79 (1): 152–160.

    PubMed  CAS  Google Scholar 

  32. Riedemann NC, Guo RF, Neff TA, et al: Increased C5a receptor expression in sepsis. J Clin Invest 2002; 110 (1): 101–108.

    PubMed  Article  CAS  Google Scholar 

  33. Haviland DL, McCoy RL, Whitehead WT, et al: Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. J Immunol 1995; 154 (4): 1861–1869.

    PubMed  CAS  Google Scholar 

  34. Zahedi R, Braun M, Wetsel RA, et al: The C5a receptor is expressed by human renal proximal tubular epithelial cells. Clin Exp Immunol 2000; 121 (2): 226–233.

    PubMed  Article  CAS  Google Scholar 

  35. Koleva M, Schlaf G, Landmann R, Gotze O, Jungermann K, Schieferdecker HL: Induction of anaphylatoxin C5a receptors in rat hepatocytes by lipopolysaccharide in vivo: mediation by interleukin-6 from Kupffer cells. Gastroenterology 2002; 122 (3): 697–708.

    PubMed  Article  CAS  Google Scholar 

  36. Schieferdecker HL, Schlaf G, Jungermann K, Gotze O: Functions of anaphylatoxin C5a in rat liver: direct and indirect actions on nonparenchymal and parenchymal cells. Int Immunopharmacol 2001; 1 (3): 469–481.

    PubMed  Article  CAS  Google Scholar 

  37. Paine R 3rd, Rolfe MW, Standiford TJ, Burdick MD, Rollins BJ, Strieter RM: MCP-1 expression by rat type II alveolar epithelial cells in primary culture. J Immunol 1993; 150 (10): 4561–4570.

    PubMed  CAS  Google Scholar 

  38. Riedemann NC, Guo RF, Sarma VJ, et al: Expression and function of the C5a receptor in rat alveolar epithelial cells. J Immunol 2002; 168 (4): 1919–1925.

    PubMed  CAS  Google Scholar 

  39. Krishnagopalan S, Kumar A, Parrillo JE: Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care 2002; 8 (5): 376–388.

    PubMed  Article  Google Scholar 

  40. Levy RJ, Deutschman CS: Evaluating myocardial depression in sepsis. Shock 2004; 22 (1): 1–10.

    PubMed  Article  CAS  Google Scholar 

  41. Parrillo JE, Burch C, Shelhamer JH, Parker MM, Natanson C, Schuette W: A criculating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest 1985; 76 (4): 1539–1553.

    PubMed  CAS  Article  Google Scholar 

  42. Meng X, Ao L, Meldrum DR, et al: TNF-alpha and myocardial depression in endotoxemic rats: temporal discordance of an obligatory relationship. Am J Physiol 1998; 275 (2 Pt 2): R502-R508.

    PubMed  CAS  Google Scholar 

  43. Niederbichler AD, Hoesel LM, Westfall MV, et al.: An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction. J Exp Med 2006; 203 (1): 53–61.

    PubMed  Article  CAS  Google Scholar 

  44. Yang S, Chung CS, Ayala A, Chaudry IH, Wang P: Differential alterations in cardiovascular responses during the progression of polymicrobial sepsis in the mouse. Shock 2002: 17 (1): 55–60.

    PubMed  Article  CAS  Google Scholar 

  45. Kumar A, Haery C, Parrillo JE: Myocardial dysfunction in septic shock: Part I. Clinical manifestation of cardiovascular dysfunction. J Cardiothorac Vasc Anesth 2001; 15 (3): 364–376.

    PubMed  Article  CAS  Google Scholar 

  46. Nakae H, Endo S, Inada K, Takakuwa T, Kasai T, Yoshida M: Serum complement levels and severity of sepsis. Res Commun Chem Pathol Pharmacol 1994; 84 (2): 189–195.

    PubMed  CAS  Google Scholar 

  47. Bengtson A, Heideman M: Anaphylatoxin formation in sepsis. Arch Surg 1988; 123 (5): 645–649.

    PubMed  CAS  Google Scholar 

  48. de Boer JP, Creasey AA, Chang A, et al: Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern. Infect Immun 1993; 61 (10): 4293–4301.

    PubMed  Google Scholar 

  49. Smedegard G, Cui LX, Hugli TE: Endotoxin-induced shock in the rat. A role for C5a. Am J Pathol 1989: 135 (3): 489–497.

    PubMed  CAS  Google Scholar 

  50. Riedemann NC, Guo RF, Hollmann TJ, et al.: Regulatory role of C5a in LPS-induced IL-6 production byneutrophils during sepsis. FASEB J 2004; 18(2): 370–372.

    PubMed  CAS  Google Scholar 

  51. Guo RF, Riedemann NC, Bernacki KD, et al:, Neutrophil C5a receptor and the outcome in a rat model of sepsis. FASEB J 2003; 17 (13): 1889–1891.

    PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Pathology, University of Michigan Medical School, 1301 Catherine Road, 48109-0602, Ann Arbor, Michigan

    Laszlo M. Hoesel, Hongwei Gao & Peter A. Ward

Authors
  1. Laszlo M. Hoesel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hongwei Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter A. Ward
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter A. Ward.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hoesel, L.M., Gao, H. & Ward, P.A. New insights into cellular mechanisms during sepsis. Immunol Res 34, 133–141 (2006). https://doi.org/10.1385/IR:34:2:133

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/IR:34:2:133

Key Words

  • Sepsis
  • Neutrophils
  • Complement system
  • Multiorgan failure
  • Cardiomyocytes